RxDoctor Payments Data

Tyler Tidwell, DPM

Podiatrist · Newburgh, INNPI 1629462635

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,183 of the $7,656 with a category attached, or 67.7%. 22 manufacturers reported payments, led by Integra Lifesciences Corporation at 26.5% of the total. Reporting peaked in 2019 at $3,828 and has fallen 90.7% since, to $356 in 2025.

$7,656in general payments, 2019–2025

Across 223 payments — averaging $34.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$2K
  • Stryker$2K
  • Treace Medical Concepts, Inc.$1K
  • Organogenesis Inc.$814
  • Medical Device Business Services, Inc.$315
  • Smith+Nephew$258
  • plus $989 from 16 others

What the payments were for

  • Travel & lodging$2,15828%
  • Food & beverage$5,18368%
  • Education$3154%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,656 in reported general payments places this provider in the 80th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$323,167
Medicare patients
754
Services billed
2,875

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole38$964
Doxycycline Monohydrate34$805
Terbinafine Hcl49$709
Clindamycin Hcl39$404
Cephalexin37$201
Ciclopirox15$176
Mupirocin20$147
Methylprednisolone27$146
Ciprofloxacin Hcl21$128
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$93
Meloxicam15$20

Paid to pharmacies, not to this prescriber.

Other podiatrist in Newburgh

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →